Trecator-sc
Indicated to manage tuberculosis to support lung function.
- Category
- Antibiotics
- Active ingredient
- Ethionamide
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 250mg
Trecator-sc details
- Condition
- Tuberculosis
- Therapeutic class
- Tuberculostatic Agent
- Pharmacological class
- Thioamide
- Contraindications
- severe hepatic impairment; hypersensitivity
- Precautions and warnings
- monitor liver function; monitor blood glucose
- Minor side effects
- nausea; anorexia
- Moderate side effects
- peripheral neuropathy; mental depression
- Serious side effects
- hepatitis, requires immediate medical attention
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Patient summary
- Indicated to manage tuberculosis to support lung function.
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Wyeth
- Onset Time
- 1–2 hours
- Duration
- 12–24 hours
- Storage instructions
- Store in a cool, dry place.
- Drug interactions
- alcohol; cycloserine; rifampicin
- Age restrictions
- Use with caution in all age groups; monitor liver function.
Mechanism of action
Trecator-SC is an antimycobacterial agent that inhibits peptide synthesis in sensitive mycobacteria.
Pregnancy and breastfeeding
Pregnancy: Use only if clearly indicated after physician assessment. Breastfeeding: Consult physician.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Trecator-sc
Trecator-sc contains ethionamide, an active agent used in the management of tuberculosis. Produced by Wyeth, the medication is supplied as a 250mg tablet. Ethionamide is commonly incorporated into broader medical plans for bacterial infection, and therapy is typically coordinated by a clinician to ensure the treatment aligns with individual requirements.
Trecator-sc availability in Asia
Trecator-sc is registered across 13 markets including Thailand, Malaysia and the Philippines, with availability also in Indonesia, Taiwan and South Korea. Accessing specialised anti-infective agents can be difficult for those based far from a well-stocked facility. Generic ethionamide, often manufactured in India, offers a more affordable alternative for patients across these regions. Such treatment is typically managed under the direct care of a physician.